Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 25Cetuximab 12Radiotherapy 11Docetaxel 11Fluorouracil 9Carboplatin 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 8pembrolizumab 7Magnetic Resonance Spectroscopy 7Radiation 6Surveys and Questionnaires 5Specimen Handling 5Drug Therapy 5toripalimab 4Standard of Care 4Celecoxib 41,2-diaminocyclohexaneplatinum II citrate 4X-Rays 3Platinum 3Paclitaxel 3Nutritional Status 3Interviews as Topic 3Hydroxyurea 3Counseling 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Resistance Training 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Laryngeal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡